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Sun-Sensitizing Effects of PKCε Shine 
on Multiple Mouse Strains
Mitchell F. Denning1
Like many skin phenotypes, susceptibility to carcinogenesis is profoundly influ-
enced by genetic background. Sand et al. (this issue) explored the sensitizing 
effects of epidermal protein kinase C ε (PKCε)expression in the hairless SKH-1 
mouse strain commonly used in UV carcinogenesis studies. They reported that 
PKCε overexpression profoundly sensitized these mice to UV skin carcinogenesis 
and activated oncogenic pathways similar to those reported in FVB/N mice.
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Anyone who has witnessed the diverse 
shades of sunburned skin on dis-
play at the beach can appreciate the 
importance of genetic background on 
the response of skin to UV radiation. 
Likewise, invest igators characterizing 
transgenic mice are aware of the impor-
tance of genetic background on phe-
notype because strain-specific effects 
are frequently reported. Differences in 
mouse strain susceptibility to carcino-
genesis, including UV skin carcinogen-
esis, are well known, and the genetic 
loci responsible for some of the differ-
ences have been identified, including 
some not related to skin pigmentation. 
The study by Sand and colleagues 
(2010, this issue) examines the sensitiz-
ing effects of protein kinase C ε (PKCε) 
overexpression on UV carcinogenesis in 
two mouse strains, FVB/N and SKH-1. 
Their findings highlight the potent effect 
of PKCε in enhancing skin carcinogen-
esis regardless of genetic background 
and shed light on the potential signal-
ing pathways involved.
PKcε and skin carcinogenesis
The PKC family of serine/threonine 
protein kinases occupies a central 
node in numerous growth factor and 
hormone receptor signal transduction 
pathways. These kinases have also been 
studied extensively as targets of the 
mouse skin tumor promoter, TPA, which 
is commonly used in “two-stage” mouse 
skin chemical carcinogenesis studies. 
Keratinocytes express at least five PKC 
isoforms (α, δ, ε, η, and ζ), each with 
a unique function in normal epidermal 
biology. Recent studies have focused on 
understanding biological functions of 
the individual PKC isoforms in UV skin 
carcinogenesis and identifying substrates 
relevant to these functions.
Verma and co-workers at the 
University of Wisconsin–Madison have 
generated and characterized trans-
genic mice expressing individual PKC 
isoforms in their epidermis under the 
control of the K14 promoter. These stud-
ies have been instrumental in clarifying 
the divergent effects of PKC isoforms on 
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skin cancer etiology for both chemical 
and UV radiation carcinogenesis proto-
cols. PKCε transgenic mice have been 
especially interesting because they are 
much more sensitive to both chemi-
cal and UV carcinogenesis (Reddig 
et al., 2000; Wheeler et al., 2004). 
Furthermore, these mice quickly devel-
op metastatic squamous cell carcino-
mas (SCCs) when exposed to either UV 
radiation or chemical carcinogens, with 
little evidence for the benign papilloma 
precursor stage commonly observed 
in carcinogenesis experiments (Jansen 
et al., 2001; Wheeler et al., 2003). The 
high SCC frequency makes the PKCε 
transgenic model useful in modeling 
malignant conversion and progression 
to more aggressive tumor types. In skin 
cancer patients, this conversion step is 
often rate limiting because premalignant 
actinic keratoses or patches of keratino-
cytes with mutant p53 can be present for 
years before converting to SCC.
Sand et al. (2010) have extended 
this work by crossing the PKCε trans-
gene, initially on the inbred FVB/N 
strain, onto the outbred hairless SKH-1 
strain. SKH-1 mice are very sensitive 
to UV carcinogenesis and are com-
monly used because of this sensitivity 
and their lack of hair, which facilitates 
UV exposure. PKCε overexpression in 
SKH-1 mice decreased SCC latency and 
increased tumor yield and multiplic-
ity, comparable to observations in the 
original FVB/N background (Wheeler et 
al., 2004). FVB/N mice are highly sensi-
tive to skin carcinogenesis and already 
have an exceptionally high papilloma-
to-carcinoma conversion frequency, 
higher than SENCAR, CD-1, BALB/c, 
and C57BL/6 mice (Hennings et al., 
1993). Thus, it is remarkable that epi-
dermal PKCε overexpression can further 
increase the carcinogenesis sensitivity 
of this strain.
Sun signaling mechanisms
Several mechanisms for the enhanced 
skin carcinogenesis observed in PKCε 
transgenic mice have been suggested. 
In the FVB/N strain, PKCε overexpres-
sion does not influence the initial 
UV-induced DNA damage, but does 
inhibit the apoptotic response to UV, 
a major tumor suppressor mechanism 
(Wheeler et al., 2004). At least two pos-
sible mechanisms may account for this 
resistance to apoptosis. First, PKCε mice 
express reduced amounts of Fas ligand 
(FasL), Fas, Fas-associated death domain 
protein (FADD), and Bid cleavage to 
tBid in response to UV (Aziz et al., 
2009). Because Fas activation by UV is 
in part required for UV apoptosis, the 
decrease in Fas pathway components 
may be sufficient to reduce apoptosis. 
Second, PKCε mice have increased 
levels of activating signal transducer 
and activator of transcription 3 (STAT3) 
phosphorylation on Ser727 and Tyr705, 
and PKCε can bind and phosphorylate 
STAT3 on Ser727 (Aziz et al., 2007). 
STAT3 is a key survival molecule for 
keratinocytes to resist UV apoptosis, 
and it is constitutively active in both 
mouse and human SCCs (Sano et al., 
2005). Other pathways, such as phos-
phoinositide 3-kinase, PI3K/Akt, are 
more active in PKCε mice and may also 
contribute to enhanced survival. The 
STAT3 and PI3K/Akt pathways are also 
active in PKCε transgenic SKH-1 mice; 
thus, resistance to UV apoptosis is like-
ly but has not been reported.
Increased proliferation is also 
a key indicator of carcinogenesis 
susceptibility among different mouse 
strains, and PKCε transgenic mice in 
both FVB/N and SKH-1 backgrounds 
exhibited an increased proliferative 
response to UV radiation (Wheeler 
et al., 2004). STAT3 phosphorylation 
and activation in PKCε mice may also 
enhance the proliferative response to 
UV and TPA. The activation of ERK1/2 
was also elevated in PKCε mice, pro-
viding yet another signaling pathway 
for enhanced cell proliferation.
The strongest evidence to explain 
the oncogenic effects of PKCε involves 
the proinflammatory cytokine tumor 
necrosis factor-α (TNF-α). TNF-α is 
induced by UV radiation and other 
tumor promoters such as TPA, and 
TNF receptor–null mice are resistant 
to UV carcinogenesis (Moore et al., 
1999). PKCε mice have dramatically 
enhanced TNF-α production and sig-
naling in response to UV radiation, 
and inhibition of TNF-α synthesis with 
pentoxifylline is reported to inhibit 
chemical carcinogenesis (Wheeler et 
al., 2003). The PKCε mice elicit a mas-
sive cytokine response to TPA or UV 
exposure, which was associated with 
the destruction of interfollicular epi-
dermal keratinocytes and regenerative 
hyperplasia from hair follicles where 
bulge stem cells reside (Wheeler et al., 
2003, 2004). PKCε transgenic mice on 
Figure 1. Signaling mechanisms of PKCε in UV carcinogenesis. PKCε can promote UV skin cancer 
formation by multiple mechanisms. PKCε inhibits UV apoptosis by reducing FasL/Fas/FADD signaling, 
as well as by promoting the STAT3 survival pathway. Enhanced STAT3 and extracellular signal-related 
kinase1/2 activation in PKCε transgenic mice also can enhance keratinocyte proliferation. Enhanced 
TNF-α signaling by PKCε overexpression is important for regenerative hyperplasia, which contributes to 
skin tumorigenesis. Note that the mechanism of PKCε activation and regulation of PKCε levels by UV is 
unclear. ERK, extracellular signal-related kinase; FADD, Fas-associated death domain protein; FasL, Fas 
ligand; MEK, mitogen-activated kinase; PKCε, protein kinase C ε; STAT, signal transducer and activator of 



















both FVB/N and SHK-1 backgrounds 
developed a spontaneous myelopro-
liferative disorder by 6 months of age, 
resulting in widespread neutrophil and 
eosinophil proliferation, mobiliza-
tion, and infiltration of multiple organs 
(Wheeler et al., 2005b). This myelopoi-
esis was associated with elevated serum 
cytokines (G-CSF, IL-5, IL-6), although 
it was not inhibited by the TNF-α syn-
thesis inhibitor pentoxifylline, or when 
PKCε transgenic mice were crossed 
onto a TNF-α null background. Basal 
TNF-α levels were not elevated in these 
mice, making it unlikely that TNF-α 
played any role in the myeloprolifera-
tive disorder. However, UV-induced 
epidermal destruction in PKCε trans-
genic mice was partially blocked in a 
TNF-α-null background, implicating 
TNF-α in regenerative hyperplasia and 
the ensuing increase in UV-induced 
SCCs (Wheeler et al., 2004).
areas in need of further clarification
One area in need of clarification is 
the regulation of PKCε expression 
and activity during skin carcinogen-
esis. PKCε expression is reported to 
be lost in human and mouse SCCs 
induced by UV or DMBA/TPA in both 
wild-type and PKCε transgenic mice 
as determined by immunohistochemi-
cal staining (Reddig et al., 2000; 
Wheeler et al., 2005a). However, this 
staining also indicated high PKCε 
levels in epidermal keratinocytes 
adjacent to the SCCs (Wheeler et al., 
2005a). One possibility is that the 
adjacent PKCε-positive tissue is the 
source of cytokine production, such 
as TNF-α, which drives inflammation 
and proliferation in the tumor itself. 
Thus, PKCε may not be acting in a 
cell-autonomous fashion. In contrast, 
immunohistochemistry in the study by 
Sand et al. (2010) detected high levels 
of PKCε in SCCs from UV-induced 
tumors in SKH-1 mice. PKCε mRNA 
levels have not been reported in either 
wild-type or PKCε transgenic tumors, 
but these may provide a more repro-
ducible measure of PKCε expression. 
Resolving this discrepancy is criti-
cal to understanding the oncogenic 
mechanisms of PKCε and to more 
fully evaluate the relevance of PKCε 
overexpression in transgenic mice to 
human skin carcinogenesis.
It is also unclear how—or even 
whether—PKCε is activated directly 
in response to UV irradiation. Clearly, 
multiple acute UV signaling path-
ways are enhanced in PKCε transgenic 
mice, which may be due to the altered 
cytokine milieu or to other altera-
tions from baseline in these mice. UV 
radiation can trigger the clustering of 
multiple growth factor and cytokine 
receptors, and these can couple to 
phospholipase C to activate PKCε via 
the canonical diacylglycerol path-
way. These initial UV signaling events, 
which have not yet been investigated, 
would be important to understand 
fully the role of endogenous PKCε in 
UV signaling.
Finally, it would be very useful to 
determine whether PKCε over expression 
would enhance the susceptibility 
of mouse strains that are ordin arily 
resistant to UV or chemical skin 
carcinogenesis. Would PKCε over-
expression alter the recessive resist-
ance mechanisms that typify strains 
such as BALB/c? Such studies might 
shed more light on differences in UV 
sensitivity among mouse strains, and, 
by extension, among people who 
spend a day at the beach.
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Clinical Implications
•  Mouse strains vary substantially in their sensitivities to UV 
carcinogenesis, just as there are important genetic contributions to 
UV carcinogenesis in humans. This extends well beyond the obvious 
pigmentation differences.
•  Experiments in genetic strains of mice lead the way in uncovering 
mechanisms of UV carcinogenesis in humans.
•  For the future: compounds that inhibit PKCε expression in humans may 
prevent the conversion of actinic keratoses to squamous cell carcinomas.
